Literature DB >> 31880151

Ferroelectricity in Ethylammonium Bismuth-Based Organic-Inorganic Hybrid: (C2H5NH3)2[BiBr5].

Ryszard Jakubas1, Anna Ga Gor2, Maciej J Winiarski2, Maciej Ptak2, Anna Piecha-Bisiorek1, Agnieszka Ciżman3.   

Abstract

The (C2H5NH3)2[BiBr5] (EBB) crystals adopt the one-dimensional (1D) polymeric anionic form [BiBr5]∞2-, which is preferred by halobismuthates(III) exhibiting polar properties and realized in R2MX5 stoichiometry. Differential scanning calorimetry and dilatometric measurements reveal reversible structural phase transitions: at 160 K (phase I → phase II) and 120 K (phase II → phase III). The resolved crystal structures of EBB show the centrosymmetric space group in phase I (Aeam), polar (Pca21) in phase II, and polar (Aea2) in phase III. The presence of dielectric hysteresis loops in phases II and III evidence ferroelectric properties. The dielectric response [ε*(ω,T)] of EBB close to 160 K is characteristic of ferroelectrics with a critical slowing down process. The molecular mechanism of a paraelectric-ferroelectric phase transition at 160 K is explained as "order-disorder" (assigned to the dynamics of the ethylammonium cations) and dominating "displacive" (related to strong distortion of the 1D anionic network). The optical band gap obtained from UV-vis measurements is about 2.6 eV. The conduction band minimum is formed by the hybridized Bi 6p and Br 4p states. An analysis of the CSD results for haloantimonates(III) and halobismuthates(III) ferroelectrics characterized by [MX4]-, [M2X9]3-, [MX5]2-, and [M2X11]5- anions is given.

Entities:  

Year:  2019        PMID: 31880151     DOI: 10.1021/acs.inorgchem.9b03193

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  1 in total

1.  Towards ferroelectricity-inducing chains of halogenoantimonates(iii) and halogenobismuthates(iii).

Authors:  Magdalena Owczarek; Przemysław Szklarz; Ryszard Jakubas
Journal:  RSC Adv       Date:  2021-05-13       Impact factor: 3.361

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.